welcome
The Roose lab focuses on understanding cell fate decisions driven by cell-cell interactions and signaling pathways, in the context of cancer, autoimmune diseases, and COVID-19. Our collaborative research programs benefit from many technology platforms, such as organoids, CyTOF, single cell RNAseq, spectral flow, mouse models, and patient samples.
Dr. Roose is a co-founder of the Bakar ImmunoX initiative at UCSF and a co-lead investigator on the UCSF Endeavor Program that focuses on cancer metastasis, funded through the Mark Foundation for Cancer Research.
Dr. Roose is a co-founder of the Bakar ImmunoX initiative at UCSF and a co-lead investigator on the UCSF Endeavor Program that focuses on cancer metastasis, funded through the Mark Foundation for Cancer Research.
latest news
We are grateful for the financial support from the following agencies:
- NIH/NIAID
- NIH/NCI
- Mark Foundation for Cancer Research
- Bakar ImmunoX CoProject
- Shorenstein Pancreatic Cancer Fund
- AutoImmuno Profiler Program with Eli Lilly
- SRA with 3T Biosciences
- SRA with Senti Biosciences